An estimated 5 billion people — two-thirds of the world’s population — do not have access to surgery because of a lack of facilities, money and trained surgeons and anesthesiologists.

It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks.

A business plan for a robotic neurosurgical device invented by Vanderbilt University engineers won top honors last week at the sixth annual TechVenture Challenge.

Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14.

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey.

Robert Lefkowitz, M.D., who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on March 31.